Abbonarsi

Randomized evaluation of decision support interventions for atrial fibrillation: Rationale and design of the RED-AF study - 28/04/22

Doi : 10.1016/j.ahj.2022.02.010 
Aubrey E. Jones, PharmD a, Madeleine M. McCarty, BS a, Juan P. Brito, MBBS b, Peter A. Noseworthy, MD b, c, Kerri L. Cavanaugh, MD, MHS, AB d, Kenzie A. Cameron, PhD, MPH, FACH e, Geoffrey D. Barnes, MD, MSc f, Benjamin A. Steinberg, MD, MHS, FACC, FHRS g, Daniel M. Witt, PharmD, FCCP, BCPS h, George H. Crossley, MD i, Rod Passman, MD j, Preeti Kansal, MD j, Ian Hargraves, PhD b, Monika Schmidt, DNP, AGNP-C, AACC k, Elizabeth Jackson, MD l, Adriana Guzman, BA e, Anthony Ariotti, BS a, Mandy L. Pershing, MS a, Jennifer Herrick, MS m, Victor M. Montori, MD b, Angela Fagerlin, PhD a, n, Elissa M. Ozanne, PhD a,

STEP-UP AFIB Writing Group

a Department of Population Health Sciences, University of Utah School of Medicine, SLC, UT 
b Knowledge and Evaluation Research (KER) Unit, Mayo Clinic, Rochester, MN 
c Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 
d Department of Medicine, Division of Nephrology & Hypertension, Vanderbilt University Medical Center, Nashville, TN 
e Department of Medicine, Division of General Internal Medicine and Geriatrics, Northwestern University, Feinberg School of Medicine, Chicago, IL 
f Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 
g Division of Cardiovascular Medicine, University of Utah School of Medicine, SLC, UT 
h Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT 
i Department of Medicine, Division of Cardiology, Vanderbilt University Medical Center, Nashville, TN 
j Department of Medicine, Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, IL 
k Department of Medicine, US Department of Veterans Affairs, Nashville, TN 
l Division of Cardiovascular Disease, University of Alabama Birmingham, Birmingham, AL 
m Department of Internal Medicine, Division of Epidemiology, University of Utah School of Medicine, SLC, UT 
n VA Informatics Decision-Enhancement and Analytic Sciences (IDEAS) Center for Innovation, Salt Lake City, UT 

Reprint requests: Elissa M. Ozanne, PhD, Department of Population Health Sciences, Spencer Eccles Fox School of Medicine at the University of Utah, 295 Chipeta Way, Williams Building, Room 1N410, Salt Lake City, UT 84108.Department of Population Health SciencesSpencer Eccles Fox School of Medicine at the University of Utah295 Chipeta Way, Williams Building, Room 1N410Salt Lake CityUT84108

Abstract

Background

Shared decision making (SDM) improves the likelihood that patients will receive care in a manner consistent with their priorities. To facilitate SDM, decision aids (DA) are commonly used, both to prepare a patient before their clinician visit, as well as to facilitate discussion during the visit. However, the relative efficacy of patient-focused or encounter-based DAs on SDM and patient outcomes remains largely unknown. We aim to directly estimate the comparative effectiveness of two DA’s on SDM observed in encounters to discuss stroke prevention strategies in patients with atrial fibrillation (AF).

Methods

The study aims to recruit 1200 adult patients with non-valvular AF who qualify for anticoagulation therapy, and their clinicians who manage stroke prevention strategies, in a 2x2 cluster randomized multi-center trial at six sites. Two DA’s were developed as interactive, online, non-linear tools: a patient decision aid (PDA) to be used by patients before the encounter, and an encounter decision aid (EDA) to be used by clinicians with their patients during the encounter. Patients will be randomized to PDA or usual care; clinicians will be randomized to EDA or usual care.

Results

Primary outcomes are quality of SDM, patient decision making, and patient knowledge. Secondary outcomes include anticoagulation choice, adherence, and clinical events.

Conclusion

This trial is the first randomized, head-to-head comparison of the effects of an EDA versus a PDA on SDM. Our results will help to inform future SDM interventions to improve patients’ AF outcomes and experiences with stroke prevention strategies.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2022  The Authors. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 248

P. 42-52 - Giugno 2022 Ritorno al numero
Articolo precedente Articolo precedente
  • Design and rationale for the supermarket and web-based intervention targeting nutrition (SuperWIN) for cardiovascular risk reduction trial
  • Sarah C. Couch, Robert N. Helsley, Francesca U. Siegel, Brian E. Saelens, Michael Magazine, Mark H. Eckman, Suzanne Summer, Matthew Fenchel, Eileen C. King, Deepak L. Bhatt, Dylan L. Steen
| Articolo seguente Articolo seguente
  • Virtual AppLication-supported Environment To INcrease Exercise (VALENTINE) during cardiac rehabilitation study: Rationale and design
  • V. Swetha Jeganathan, Jessica R. Golbus, Kashvi Gupta, Evan Luff, Walter Dempsey, Thomas Boyden, Melvyn Rubenfire, Brahmar Mukherjee, Predrag Klasnja, Sachin Kheterpal, Brahmajee K. Nallamothu

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.